RxDoctor Payments Data

Dileep Yavagal, MD

Neurology · Miami, FLNPI 1689661217

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.7%.

$18,841in general payments, 2019–2025

Across 98 payments — averaging $192.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Medtronic$3K
  • BTG International Inc.$3K
  • Depuy Synthes Products, Inc.$3K
  • Corindus Inc.$3K
  • Microvention, Inc.$874
  • plus $4K from 15 others
$118,557in research payments, 2019–2025

Across 32 payments — averaging $3704.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Route 92 Medical, Inc.$44K
  • Medical Device Business Services, Inc.$44K
  • Sunovion Pharmaceuticals Inc.$30K

What the payments were for

  • Consulting fees$7,80041%
  • Travel & lodging$5,81731%
  • Food & beverage$5,22428%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,841 in reported general payments places this provider in the 80th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$38,375
Medicare patients
49
Services billed
130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate53$192
Atorvastatin Calcium19$41
Prednisone13$11

Paid to pharmacies, not to this prescriber.

Other neurology in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →